Systemic treatment of non-small cell lung cancer brain metastases

about

Systemic treatment of non-small cell lung cancer brain metastases

Item

http://www.wikidata.org/entity/Q37727648

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 20 December 2016

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Systemic treatment of non-small cell lung cancer brain metastases

@en

Systemic treatment of non-small cell lung cancer brain metastases.

@nl

type

Item

label

Systemic treatment of non-small cell lung cancer brain metastases

@en

Systemic treatment of non-small cell lung cancer brain metastases.

@nl

prefLabel

Systemic treatment of non-small cell lung cancer brain metastases

@en

Systemic treatment of non-small cell lung cancer brain metastases.

@nl

P1476

Systemic treatment of non-small cell lung cancer brain metastases

@en

P2093

Ida Cedrych

http://www.w3.org/2001/XMLSchema#string

Marian Reinfuss

http://www.w3.org/2001/XMLSchema#string

Tomasz Walasek

http://www.w3.org/2001/XMLSchema#string

P2860

EGF receptor gene mutations are common in lung cancers from "never smokers" and are associated with sensitivity of tumors to gefitinib and erlotinib

EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy.

Anaplastic lymphoma kinase inhibition in non-small-cell lung cancer.

Paclitaxel-carboplatin alone or with bevacizumab for non-small-cell lung cancer

Gefitinib in patients with brain metastases from non-small-cell lung cancer: review of 15 clinical cases.

Whole brain radiation therapy with or without stereotactic radiosurgery boost for patients with one to three brain metastases: phase III results of the RTOG 9508 randomised trial.

Front-line paclitaxel/cisplatin-based chemotherapy in brain metastases from non-small-cell lung cancer.

Temozolomide in patients with advanced non-small cell lung cancer with and without brain metastases. a phase II study of the EORTC Lung Cancer Group (08965).

Safety and efficacy of sunitinib for metastatic renal-cell carcinoma: an expanded-access trial.

Temozolomide added to whole brain radiotherapy in patients with multiple brain metastases of non-small-cell lung cancer: a multicentric Austrian phase II study.

P304

352-357

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.5114/WO.2016.64593

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Pawel Blecharz

Jerzy Jakubowicz

Maksymilian A Kruczała

P577

2016-12-20T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28373815

http://www.w3.org/2001/XMLSchema#string

P932

5371701

http://www.w3.org/2001/XMLSchema#string